Statistics for A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non–small cell lung cancer: Hoosier Cancer Research Network LUN 14-179
Total visits
| views | |
|---|---|
| A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non–small cell lung cancer: Hoosier Cancer Research Network LUN 14-179 | 69 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| Durm2020Pembrolizumab.pdf | 566 |
| java.util.UUID:c7b8769c-a645-46e2-abdf-8b5bd008e48c | 109 |
| java.util.UUID:3b6fe0c5-6801-4b2f-a4d4-2447ba1ee51a | 13 |
| java.util.UUID:c132c728-3020-4874-9d1f-18097c4277a2 | 5 |
Top country views
| views | |
|---|---|
| United States | 58 |
| China | 2 |
| United Kingdom | 2 |
| Malaysia | 1 |
| Ukraine | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 39 |
| Cambridge | 2 |
| Houston | 2 |
| Tower Hamlets | 2 |
| Zionsville | 2 |
| Ann Arbor | 1 |
| Beijing | 1 |
| Collegeville | 1 |
| Fairfield | 1 |
| Kiev | 1 |
| San Francisco | 1 |
| Seremban | 1 |